Related references
Note: Only part of the references are listed.Targeting the eukaryotic translation initiation factor 4E for cancer therapy
Jeremy R. Graff et al.
CANCER RESEARCH (2008)
c-Myc and eIF4F are components of a feedforward loop that links transcription and translation
Chen-Ju Lin et al.
CANCER RESEARCH (2008)
Tumorigenic activity and therapeutic inhibition of Rheb GTPase
Konstantinos J. Mavrakis et al.
GENES & DEVELOPMENT (2008)
Selective Pharmacological Targeting of a DEAD Box RNA Helicase
Lisa Lindqvist et al.
PLOS ONE (2008)
mTORC1 promotes survival through translational control of Mcl-1
John R. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation
Sunita Kumari et al.
NATURE CHEMICAL BIOLOGY (2007)
Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
Yael Mamane et al.
PLOS ONE (2007)
Enantioselective synthesis of the complex rocaglate (-)-silvestrol
Baudouin Gerard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
RNA-mediated sequestration of the RNA helicase eIF4A by pateamine A inhibits translation initiation
Marie-Eve Bordeleau et al.
CHEMISTRY & BIOLOGY (2006)
S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
N. Valerio Dorrello et al.
SCIENCE (2006)
Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2α phosphorylation
Rachid Mazroui et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo
Hans-Guido Wendel et al.
CANCER RESEARCH (2006)
Survival signaling by Notch1: Mammalian target of rapamycin (mTOR)-dependent inhibition of p53
Sathish Kumar Mungamuri et al.
CANCER RESEARCH (2006)
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
ME Bordeleau et al.
NATURE CHEMICAL BIOLOGY (2006)
Akt-regulated pathways in prostate cancer
PK Majumder et al.
ONCOGENE (2005)
eIF-4E expression and its role in malignancies and metastases
A De Benedetti et al.
ONCOGENE (2004)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen
O Novac et al.
NUCLEIC ACIDS RESEARCH (2004)
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells
S Avdulov et al.
CANCER CELL (2004)
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris
BY Hwang et al.
JOURNAL OF ORGANIC CHEMISTRY (2004)
Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to Polysomes
VK Rajasekhar et al.
MOLECULAR CELL (2003)
Mammalian stress granules represent sites of accumulation of stalled translation initiation complexes
SR Kimball et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs
JR Graff et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression
R Mazroui et al.
HUMAN MOLECULAR GENETICS (2002)
The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection
TV Pestova et al.
GENES & DEVELOPMENT (2002)
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis
Y Maeshima et al.
SCIENCE (2002)
Molecular mechanisms of translation initiation in eukaryotes
TV Pestova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure
YV Svitkin et al.
RNA (2001)
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
JR Graff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling
AR Tee et al.
ONCOGENE (2000)
Share Paper
